Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Dasatinib 63.2mg tablets |
| BNF code | 0801050ANAAAJAJ |
| Virtual Therapeutic Moiety | Dasatinib |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Caution - AMP level prescribing advised |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 26 Jun 2024 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Dasatinib anhydrous |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 63.200 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Dasatinib 63.2mg tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.